| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 13 |
| 1 | TACROLIMUS | 13 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 13 |
| 3 | TACROLIMUS OINTMENT 0.1% | 13 |
| 4 | ETOPOSIDE | 11 |
| 5 | RITUXIMAB | 11 |
| 6 | MELPHALAN HYDROCHLORIDE | 10 |
| 7 | METHOTREXATE SODIUM | 10 |
| 8 | PREDNISONE | 10 |
| 9 | MELPHALAN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PLERIXAFOR | 5 | 0.0034 |
| 1 | ONASEMNOGENE ABEPARVOVEC-XIOI | 4 | 0.0017 |
| 2 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 | 0.0009 |
| 3 | CAPLACIZUMAB | 1 | 0.0006 |
| 4 | BENDAMUSTINE HYDROCHLORIDE | 4 | 0.0005 |
| 5 | MELPHALAN HYDROCHLORIDE | 10 | 0.0004 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 2 | 0.0002 |
| 7 | ECULIZUMAB | 13 | 0.0002 |
| 8 | CAPTOPRIL | 2 | 0.0002 |
| 9 | PONATINIB HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hematopoietic Stem Cell Mobilizer [EPC] | 5 | 0.0034 |
| 1 | Complement Inhibitor [EPC] | 13 | 0.0002 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 3 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |
| 4 | Topoisomerase Inhibitor [EPC] | 11 | 0.0001 |
| 5 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 8 | Sulfone [EPC] | 1 | 0.0001 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |